Chris Alexander is an Endocrinology/Metabolic physician. OpenAlex indexes 5 publications with 207 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5012 S Us Hwy 75
Suite 300
Denison, TX 750204589
Telephone
903-416-6010Registry record last updated 4 Sept 2018.
Industry payments
39 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202513 payments
- Abbott LaboratoriesProgram year202519 payments
- Corcept TherapeuticsProgram year202512 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
52.9%RANK Ligand Inhibitor52.8%Denosumab100%Prolia0%Part D + Part B≥67 patientsBisphosphonates0.1%Risedronate Sodium100%Part D<11 patientsMetabolism & gastrointestinal
30%GLP-1 receptor agonist8.6%Ozempic63%Mounjaro28%Trulicity6%Rybelsus3%Part D≥178 patientsInsulin Analog6%Lantus Solostar15%Tresiba Flextouch U-10015%Humalog Kwikpen U-1008%Novolog Flexpen8%Humalog8%Novolog7%Toujeo Solostar7%Insulin Lispro Kwikpen U-1007%Soliqua 100-335%Fiasp Flextouch5%Basaglar Kwikpen U-1004%Insulin Lispro4%Tresiba Flextouch U-2003%Fiasp2%Humalog Kwikpen U-2002%Lyumjev2%Part D<11 patients+ 12 more classes in this area
Cardiovascular
10.1%Statin6.3%Atorvastatin Calcium47%Rosuvastatin Calcium42%Pravastatin Sodium9%Simvastatin3%Part D<11 patientsCholesterol absorption inhibitor1.4%Ezetimibe100%Part D≥61 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Composite repair of large size diameter pipe with severe metal loss defects
Journal of Pipeline Science and Engineering
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”